Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Small Cohort, Off Label Treatment Assessing the Safety and Tolerability of NMN in DHDDS-Congenital Disorder of Glycosylation (DHDDS-CDG)

NCT07572825 is registered in ClinicalTrials.gov with Eva Morava-Kozicz as lead sponsor.

NCT NCT07572825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07572825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Small Cohort, Off Label Treatment Assessing the Safety and Tolerability of NMN in DHDDS-Congenital Disorder of Glycosylation (DHDDS-CDG)
Lead sponsor
Eva Morava-Kozicz
Phase
Phase 1
Overall status
Recruiting
Start date
May 8, 2026
Completion date
August 1, 2027
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital disorder of glycosylation, dhdds-cdg, dhdds-congenital disorder of glycosylation